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Abstract
CD4 T cell-mediated help to CD8 T cells and B cells is a critical arm of the adaptive immune
system required for control of pathogen infection. CD4 T cells express cytokines and co-
stimulatory molecules that support a sustained CD8 T cell response and also enhance
generation of protective antibody by germinal center B cells. However, the molecular
components that modulate CD4 T cell functions in response to viral infection or vaccine are
incompletely understood. Here we demonstrate that inactivation of the signaling adaptor
CD2-associated protein (CD2AP) promotes CD4 T cell differentiation towards the follicular
helper lineage, leading to enhanced control of viral infection by augmented germinal center
response in chronic lymphocytic choriomeningitis virus (LCMV) infection. The enhanced
follicular helper differentiation is associated with extended duration of TCR signaling and
enhanced cytokine production of CD2AP-deficient CD4 T cells specifically under TH1 condi-
tions, while neither prolonged TCR signaling nor enhanced follicular helper differentiation
was observed under conditions that induce other helper effector subsets. Despite the struc-
tural similarity between CD2AP and the closely related adaptor protein CIN85, we observed
defective antibody-mediated control of chronic LCMV infection in mice lacking CIN85 in T
cells, suggesting non-overlapping and potentially antagonistic roles for CD2AP and CIN85.
These results suggest that tuning of TCR signaling by targeting CD2AP improves protective
antibody responses in viral infection.
Author summary
Enhancing the production of protective antibodies in response to infection or vaccine is
critically important for host protection. However, we have only limited knowledge about
molecular targets to enhance functions of CD4 helper T cells that are essential for anti-
body affinity maturation and class switching. In this work, we found that inhibiting the
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function of the adaptor molecule CD2AP results in enhanced antibody responses and
improved protection of mice from chronic infection by LCMV. Mice lacking CD2AP spe-
cifically in T cells showed enhanced CD4 T cell differentiation towards the follicular
helper subset, which is a critical regulator of antibody responses, and generated more ger-
minal center B cells leading to production of mutated, protective antibodies. This effect
was specific to CD4 T cells in type-I immune responses, associated with viral infection,
while deletion of CD2AP had little impact on CD4 T cells in type-II immune responses or
CD8 T cells. Our results thus suggest that CD2AP can be a specific target to enhance anti-
viral protective immunity during viral infection or vaccination.
Introduction
CD4 T lymphocytes are critical mediators of the adaptive immune response to infection [1].
Upon encountering cognate antigen as peptide-MHC (pMHC) complexes on antigen present-
ing cells in the lymphoid organs, they initiate clonal expansion and undergo differentiation
into effector cells, depending on the cytokine milieu initially established by innate immune
cells [2]. In response to viral infection, differentiation of activated CD4 T cells is directed
towards an IFN-γ-producing subset, referred to as TH1, that also produces IL-2 and TNF-α
and enhances cellular immune responses by CD8 T cells and macrophages. Activated CD4 T
cells also differentiate into the follicular helper (TFH) cells that migrate to germinal centers
(GCs) [3]. During viral infection, TFH cells provide help signals to B cells for antibody affinity
maturation through their expression of co-stimulatory ligands and cytokines, such as CD40L
and IL-21, and direct immunoglobulin class switching to the antiviral IgG2a/c subclass by
secreting IFN-γ [4]. Thus, understanding the molecular mechanisms governing CD4 T cell
responses through either TCR-dependent or cytokine-dependent signals can yield insight into
host protection against viral infection or protective antibodies induced by vaccines.
Following ligation of the TCR by cognate pMHC complexes, re-organization of membrane
proteins and post-translational modification of signaling components ultimately result in acti-
vation of genes necessary for their proliferation and effector differentiation [5]. At the TCR-
juxta-membrane regions, the TCR itself and its proximal kinases are densely packed and sur-
rounded by adhesion molecules, such as LFA1 integrin, which together comprise the immuno-
logical synapse (IS) and facilitate quality control of TCR signals [6]. A number of previous
studies have demonstrated that repeated cycles of this brief activation of TCR fine-tune the
quality and magnitude of the activation program [7]. However, it remains unknown whether
such fine-tuning mechanisms are common across different effector subsets, or whether the
altered regulation may have impact on CD4 T cell immune responses in vivo.
The closely related proteins, CD2AP and CIN85, are scaffolding molecules that possess
three tandem SH3 domains, a proline rich domain, and a C-terminal coiled-coil domain that
mediates their hetero/homodimerization [8]. CD2AP was originally identified via a yeast two-
hybrid screen as an interacting partner of the adhesion molecule CD2 and a dominant negative
form expressed in Jurkat T cells prevented formation of the immunological synapse [9]. How-
ever, in naive T cells from AND TCR transgenic mice lacking CD2AP, formation of the immu-
nological synapse was intact, suggesting that CD2AP functions independently of CD2 in
primary T cells [10]. Interestingly, following stimulation with pMHC, activation of proximal
kinases and degradation of TCR are delayed, leading to prolonged TCR activation and
enhanced cytokine production in vitro [10]. However, the role of CD2AP in tuning of TCR sig-
naling in T cell immune responses or the impact of altered TCR signaling quality in vivo
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caused by Cd2ap deficiency has not been defined due to a fatal kidney disease that develops
around 3 weeks of age in Cd2ap−/− mice [11].
Here, we generated T cell-specific Cd2ap−/− deficient mice and show that CD2AP deficiency
enhances control of chronic viral infection by augmenting antiviral TFH and GC responses. In
contrast, TFH and GC responses were minimally altered when the mice were immunized with
sheep red blood cells (SRBCs), which are prone to elicit type 2 responses [12]. TCR signaling
in Cd2ap−/− CD4 T cells was prolonged specifically under TH1 conditions in vitro, resulting in
increased production of IFN-γ, while CD2AP was dispensable for temporal tuning of TCR sig-
nals in TH2 or TH17 cells. These results demonstrate that CD2AP-dependent tuning of TCR
signaling in CD4 T cells is TH subset-specific and that CD2AP may be an effective target to
accelerate the development of protective antibodies in antiviral immune responses.
Results
TFH differentiation is enhanced in CD2AP-deficient mice late in acute viral
infection
To conduct analyses of function of CD2AP in T cells in vivo, we generated the Cd2ap-flox
allele, in which expression of cre recombinase results in deletion of exon 2 (S1A Fig). This
allele was bred to Cd4-cre to inactivate Cd2ap in T cells. Numbers of mature CD4 and CD8
single positive thymocytes and CD4 and CD8 T cells in the spleen were comparable between
Cd4-cre+ Cd2apF/F and control Cd2apF/F mice (S1B and S1C Fig).
To define the role of CD2AP in T cells in vivo, we infected Cd4-cre+ Cd2apF/F and control
Cd2apF/F littermate control mice with the Armstrong strain of lymphocytic choriomeningitis
virus (LCMV), which elicits acute antiviral responses and is cleared by CD8 T cells. At the
peak of the T cell response on day 8 after infection, no difference was seen in numbers of total
CD8 T cells, KLRG1+ short-lived effector CD8 T cells or that of LCMV glycoprotein (gp)-spe-
cific CD8 T cells between Cd4-cre+ Cd2apF/F and Cd2apF/F mice (Fig 1A, 1B and 1D), suggest-
ing that CD2AP is not required for normal CD8 T cell responses to acute LCMV infection.
Comparable numbers of LCMV-gp-specific CD4 T cells also were detected in both genotypes
eight days after infection (Fig 1C and 1D), suggesting that CD2AP is dispensable for priming
and initial expansion of LCMV-specific CD4 T cells. Both Cd2ap−/− and control LCMV-spe-
cific CD4 T cells differentiated into Ly6C+ TH1 effector cells or TFH cells as defined by CXCR5
and PD-1 expression on day 8 after infection (Fig 1E and 1F). Accordingly, we did not observe
a difference in either frequency or absolute number of Fas+ GL7+ GC B cells at this time point
(Fig 1E and 1F). At a later time-point (day 22), however, the frequency and absolute number
of total and LCMV-specific CXCR5+ PD-1+ TFH cells as well as GL7
+ Fas+ GC B cells was sig-
nificantly increased in Cd4-cre+ Cd2apF/F mice (Fig 1G and 1H). These results indicate that
Cd2ap-deficiency enhances CD4 T cell differentiation into the TFH subset following initial
bifurcation between TH1 effector and TFH fates early in infection, and augments GC B cell
responses.
To determine whether TFH differentiation of Cd2ap−/− CD4 T cells is also enhanced by
immunization that induces other types of CD4 T cell responses, we analyzed the GC response
after immunization of Cd4-cre+ Cd2apF/F and Cd2apF/F mice with SRBCs, which predomi-
nantly induces development of IL-4 producing CD4 T cells [13, 14]. While in the absence of
CD2AP, a statistically insignificant trend in increased TFH and GC responses was seen at day
12 following immunization, a relatively late time point when antigen levels are declining [15]
(Fig 2A–2H), numbers of TFH and GC B cells were comparable between Cd4-cre+ Cd2apF/F
and Cd2apF/F mice both at a relatively early time point, day 6, and a later time point day 22
(S2A–S2D Fig). In addition, we found no significant differences in TFH and GC B cell numbers
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between Cd4-cre+ Cd2apF/F and Cd2apF/F mice following immunization with NP-CGG precip-
itated in aluminum salts (S2E and S2F Fig), which also induces a preferential TH2 biased CD4
T cell response [16, 17]. These results suggested that CD2AP suppresses CD4 T cell differentia-
tion towards the TFH subset dependent on the context in which the response is induced.
Fig 1. Enhanced TFH and GC B cell responses in T cell-specific Cd2ap-deficient mice in response to acute viral infection. (A) Flow cytometric
analysis of expression of CD4, CD8 and CD44 and binding of H-2Db(gp33-41) tetramer in splenocytes 8 days after LCMV-Armstrong infection. Total
CD8 T cells and LCMV-gp33-specific CD8 T cells are shown with rectangular gates. (B) Expression of CD8 and KLRG1 in splenocytes 8 days after
LCMV-Armstrong infection. (C) Expression of CD44 and binding of I-Ab(gp66-77) tetramer in CD4+ splenic T cells 8 days after LCMV-Armstrong
infection. LCMV-gp66-specific CD4 T cells are shown with rectangular gates. (E, G) Expression of PD-1, CXCR5 and Ly6C and binding of I-Ab (gp66-
77)+ tetramer of CD4+ T cells and Fas and GL7 expression in B cells in the spleens of Cd4-cre+ Cd2apF/F and control Cd2apF/F mice 8 (E) and 22 (G)
days after infection. TFH cells and GC B cells are shown with rectangular gates. Representative plots are shown with percentages of gated cells. Statistical
analyses from 4–6 mice in 2 independent experiments are shown with means and standard deviation in (D, F, H).
https://doi.org/10.1371/journal.ppat.1007053.g001
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Fig 2. Cd2ap deficiency has a minimal impact on TFH differentiation and GC B cell responses following immunization with SRBCs. (A, B)
Flow cytometric analysis of expression of PD-1 and CXCR5 on pre-gated CD4+ B220− T cells (A) and GL7 and Fas expression on CD19+ B220+ B
Cells (B) 12 days following SRBC immunization. (C-E) Numbers and frequencies of total CD4 T cells and CXCR5+ PD-1+ TFH in the spleen of
Cd4-cre+ Cd2apF/F and control Cd2apF/F mice 12 days after immunization with SRBCs. (F-H) Numbers and frequencies of total B cells and Fas+
GL7+ GC B cells in the spleen of Cd4-cre+ Cd2apF/F and control Cd2apF/F mice 12 days after immunization with SRBCs. Data are pooled from 2
independent experiments shown as means and standard deviation.
https://doi.org/10.1371/journal.ppat.1007053.g002
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Enhanced control of chronic LCMV infection in T cell-specific Cd2ap-
deficient mice
While we observed enhanced TFH differentiation in Cd2ap-deficient mice to LCMV-Arm-
strong, CD8 CTLs rather than LCMV-specific antibodies are required for control of acute
LCMV infection [18]. To determine whether enhanced TFH differentiation seen in CD2AP
deficiency had an impact on antiviral antibody-mediated immunity, we utilized the LCMV-
clone13 (LCMV-c13) model of chronic viral infection since TFH-dependent high affinity anti-
body responses in the GCs and class-switch recombination to IgG2a/2c subclasses are required
for control of the infection [19–21]. After infection, LCMV replicated and established viremia
to a similar extent in Cd4-cre+ Cd2apF/F and control cre−Cd2apF/F mice on day 8 (Fig 3A). In
control cre−Cd2apF/F mice, viral abundance, as determined by the quantities of the LCMV gp
transcript in the plasma of mice, started to gradually decline around day 30 (Fig 3A), coincid-
ing with expansion of TFH and GC B cells in response to a surge of IL-6 production by follicu-
lar dendritic cells [19]. The decline in LCMV abundance was significantly accelerated in
Cd4-cre+ Cd2apF/F mice, with the viral titers below the limit of detection in some Cd4-cre+
Cd2apF/F mice by day 45 (Fig 3A and S3A Fig). Consistent with the accelerated clearance of
LCMV, the frequencies and numbers of total and LCMV gp-specific TFH cells in the spleen 22
days after infection were significantly increased (Fig 3B and 3D; S3B and S3C Fig), although
total numbers of LCMV-specific CD4 T cells were not changed in Cd4-cre+ Cd2apF/F mice
compared to control mice (Fig 3D). Accordingly, frequencies and numbers of GC B cells were
significantly increased in Cd4-cre+ Cd2apF/F mice compared to control mice (Fig 3C and 3E;
S3D Fig). It has been demonstrated that T follicular regulatory (TFR) cells can suppress the GC
response [22]; thus we analyzed the frequency of Foxp3+ cells within the TFH compartment,
however, we did not find differences between genotypes indicating TFR differentiation was
unimpaired (S3E and S3F Fig). Moreover, plasma from Cd4-cre+ Cd2apF/F mice exhibited ele-
vated neutralizing activity against LCMV in vitro, while titers of total anti-LCMV antibodies
with dominant IgG2c and sub-dominant IgG1 subclasses were comparable between Cd4-cre+
Cd2apF/F and control Cd2apF/F mice (Fig 3F; S3G Fig). As a measure of GC output we also
analyzed the number of memory B cells in the spleen and plasma cells in the bone marrow at
60 days following LCMV-c13 infection and observed no difference in overall numbers between
Cd4-cre+ Cd2apF/F and control Cd2apF/F, suggesting enhanced acquisition of mutations rather
than total output contributed to the phenotype (S4 Fig). Given the importance of CD4 T cell
help in promoting long-lived polyfunctional CD8 T cells we also analyzed the CD8 T cell
response at day 22 [23, 24]. Importantly, we did not detect differences in overall CD8 T cell
numbers or LCMV-specific H-2Db(gp33-41) tetramer binding T cells in Cd4-cre+ Cd2apF/F
mice compared to control mice (S5A and S5B Fig). In addition, we did not observe differences
in the polyfunctionality of LCMV-specific CD8 T cells as determined by IFN-γ and TNF-α
production (S5C Fig). These results indicate that while inactivation of CD2AP only minimally
affects the CD8 T cell response, it enhances TFH differentiation and generation of neutralizing
antiviral antibodies by augmenting B cell help.
CD2AP deficiency promotes TFH differentiation in a cell-intrinsic manner
To determine whether the increased TFH differentiation in Cd4-cre+ Cd2apF/F mice was cell-
intrinsic, we generated BM chimeras by transferring a mixture of BM cells from Cd4-cre+
Cd2apF/F or cre−Cd2apF/F mice (CD45.2) and CD45.1 WT mice into lethally irradiated CD45.1
WT mice. Following reconstitution of donor-derived hematopoiesis, the recipient mice were
infected with LCMV-c13 and contribution of Cd2ap-deficient and -sufficient cells to the TFH
compartment was examined 22 days after infection (Fig 4A). While the percentages of CD45.2
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cells in the B cell and CD44lo PD-1− naive CD4 T cell compartments were equivalent between
chimeras reconstituted with Cd4-cre+ Cd2apF/F or cre−Cd2apF/F BM cells, the contribution of
CD45.2 cells to the CXCR5+ PD-1+ TFH pool was significantly greater in chimeras receiving
Cd4-cre+ Cd2apF/F compared to control chimeras receiving cre−Cd2apF/F BM cells (Fig 4B). In
addition to the quantitative increase in TFH numbers in Cd4-cre+ Cd2apF/F mice, Cd2ap-defi-
cient TFH cells expressed elevated levels of genes that are associated with TFH functions, includ-
ing Il21, Il21r and Il17ra, and also those associating with active cell cycling (Fig 4C) [25]. We
confirmed these results by analysis of frequencies of Ki67+ cells within TFH cells and found
them to be increased in KO cells compared to WT (S3H Fig). In contrast to these changes, we
did not observe changes in expression of TFH associated molecules such as ICOS and OX-40,
Fig 3. Enhanced control of LCMV-c13 infection in Cd4-cre+ Cd2apF/F is associated with elevated TFH response. (A) Analysis of LCMV
abundance in plasma in mice as determined by LCMV gp transcript levels. Horizontal bars indicate medians. The limit of detection is shown by
a dashed line. Statistical significance was tested by Mann Whitney U-test. (B-E) Expression of B220, GL7, Fas, CD4, CD44, PD-1 and CXCR5
and binding of I-Ab (gp66-77) tetramer of splenocytes from Cd2apF/F and Cd4-cre+ Cd2apF/F mice 22 days after LCMV-c13 infection.
Representative plots are shown with percentages of gated cells. Statistical analyses from at least 7–10 mice per genotype in 2 independent
experiments are shown with means and standard deviation in (D) and (E). (F) (Left) Neutralizing activity and (Right) anti-LCMV IgG2c
antibody titers of plasma from Cd2apF/F and Cd4-cre+ Cd2apF/F mice 60 days after LCMV-c13 infection. Reduction in focus forming units
(FFU) in the presence of 1:10 dilution of plasma compared to untreated control (%Neutralization) is shown with mean and standard deviation.
Cd2apF/F: n = 7, Cd4-cre+ Cd2apF/F: n = 9.
https://doi.org/10.1371/journal.ppat.1007053.g003
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Fig 4. Cd2ap-deficiency enhances TFH differentiation in a cell-intrinsic manner. (A) Schematic of experimental strategy for the
generation of mixed BM chimeras and subsequent analysis of anti-LCMV responses. (B) Contribution of CD45.2 Cd2apF/F or Cd4-cre+
Cd2apF/F cells to B cells, activated CD4 T cells and TFH cells in the mixed BM chimeras 22 days after LCMV-c13 infection.
Representative Data from 2 independent experiments (n = 4 of each genotype) are shown with means and standard deviations.
Statistical difference was tested by Student’s t-test. (C) A volcano plot showing differentially expressed genes between Cd2ap-deficient
Tuning of TCR signaling by CD2AP
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suggesting these costimulatory pathways might not contribute to the observed phenotype (S3I
Fig). These results suggest that Cd2ap-deficient CD4 T cells are maintaining highly activated
states, potentially through enhanced TCR-dependent signaling, and establish a stable TFH pro-
gram potentially by the IL-21-IL-21R feed-forward loop and thus better support GC B cell
responses against viral infection.
CD2AP-deficiency causes sustained TCR activation specifically in TH1 cells
Our data demonstrated that TFH differentiation was enhanced by Cd2ap-deficiency specifically
in viral infection, but not in immunization with SRBCs or NP-CGG in alum. These results sug-
gest that CD2AP regulates TCR signaling in a TH-subset-specific manner. To dissect the sub-
set-specific role of CD2AP in CD4 T cells, we activated naive CD4 T cells from Cd4-cre+
Cd2apF/F and control Cd2apF/F cells under polarizing conditions that promote generation of
TH1 or TH2 cells and compared their responses to antigen receptor stimulation (Fig 5A).
While production of IL-4 under TH2 conditions was comparable between Cd2ap-deficient and
-sufficient CD4 T cells, the production of IFN-γ was increased by 3-fold in Cd2ap-deficient
TH1 cells compared to control cells (Fig 5B). Consistently, activation of the MAPK pathway
was prolonged specifically in Cd2ap-deficient TH1 compared to control TH1 cells, whereas we
did not observe the difference in TH2 cells (Fig 5C). Previous studies of CD4 T cells using
germline Cd2ap-deficient mice showed that Cd2ap−/− TCR-transgenic naive T cells are defec-
tive in TCR downregulation [10]. In polarized TH1 cells, downmodulation of surface TCRs
was significantly impaired in the absence of CD2AP, while the difference was not observed
under TH0, TH2 or TH17 conditions between Cd2ap-deficient and -sufficient CD4 T cells (Fig
5D). Furthermore, when Cd2ap-deficient and control TH1 cells were re-stimulated with plate-
bound anti-CD3 and anti-CD28 antibodies or with PMA and Ionomycin for 4 hours, similar
frequencies of cells expressed IFN-γ and TNF-α (Fig 5E and 5F). However, when they were
stimulated with plate-bound anti-CD3 and anti-CD28 antibodies for 24 hours, the frequencies
of cells that expressed IFN-γ or TNF-α during the last 2 hours of the stimulation were signifi-
cantly increased in Cd2ap-deficient TH1 cells relative to WT TH1 cells presumably due to
prolonged retention of TCR on the cell surface, which was crosslinked by the plate-bound anti-
bodies (Fig 5E and 5F). These results indicate that CD2AP deficiency prolongs TCR signaling
specifically in CD4 T cells under TH1 conditions.
CIN85 plays a non-redundant role in T cell-dependent control of LCMV
infection
CIN85 and CD2AP are closely related and may have redundant functions [8,12]. To test this,
we also generated mice in which T cells are deficient for CIN85 by breeding a Cin85-flox allele
to both Cd4-cre [26]. Cd4-cre+ Cin85F/F mice exhibited no differences in CD4 T and CD8 T
cell response to acute LCMV infection (S6 Fig). However, in contrast to Cd4-cre−Cd2apF/F
mice, Cd4-cre+ Cin85F/F mice were unable to control chronic LCMV infection with signifi-
cantly higher viral burden in the peripheral blood at days 45 and 60 after infection compared
to cre− littermate controls (Fig 6A). In addition, while all WT mice had cleared virus from the
plasma by day 80, approximately half of Cd4-cre+ Cin85F/F still exhibited high viral load (Fig
6B). The clearance phenotype was more pronounced when we infected Vav1-icre+ Cin85F/F
mice, in which all hematopoietic cells, including B cells, were deficient for Cin85 (S7A Fig),
(KO, n = 2) and -sufficient (WT, n = 2) TFH cells harvested from mixed BM chimeras 22 days after infection. Genes that were
differentially expressed by>2-fold are shown.
https://doi.org/10.1371/journal.ppat.1007053.g004
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Fig 5. Cd2ap-deficiency causes sustained TCR signaling specifically in TH1 cells in vitro. (A) Schematic of experimental strategy for culture of CD4
T cells. (B) Concentration of IFN-γ or IL-4 in supernatant measured by ELISA 24 hours after re-stimulation of polarized Cd2apF/F and Cd4-cre+
Cd2apF/F TH1 cells and TH2 cells with plate-bound anti-CD3/anti-CD28 antibodies. (C) Immunoblotting showing phosphorylation of MEK1/2 in
polarized Cd2apF/F and Cd4-cre+ Cd2apF/F TH1 or TH2 cells following re-stimulation with plate-bound anti-CD3/anti-CD28 for the indicated times at
37˚C. Anti-CD2AP, -CIN85 and ERK were used as control. Data are representative of three experiments. (D) Downregulation of surface TCR of
Cd2apF/F and Cd4-cre+ Cd2apF/F T cells that were polarized under indicated conditions. Cells were stimulated with plate-bound anti-CD3 and surface
TCR levels were quantitated at the indicated time points. Data are representative of three experiments. (E, F) Intracellular staining for IFN-γ and TNF-α
of polarized Cd2apF/F and Cd4-cre+ Cd2apF/F TH1 cells after re-stimulation with PMA and Ionomycin or plate-bound anti-CD3 and anti-CD28 for 4 or
24 hours in the presence of Brefeldin A for the last 2 hours before harvest. Representative plots (E) and statistical analyses with means and standard
deviations (F) from three experiments are shown.
https://doi.org/10.1371/journal.ppat.1007053.g005
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suggesting CIN85 plays additional roles in other hematopoietic cells in the context of LCMV-
c13 infection, potentially through B cells as previously reported [26]. However, when we ana-
lyzed mice at day 30 following infection we did not find any significant differences in either
frequency or absolute number of CD8 T cell, TFH, or GC response (S7B–S7D Fig). Consis-
tently, when we analyzed Cd4-cre+ Cin85F/F mice, the frequency of Fas+ GL7+ GC B cells was
only marginally, but insignificantly, decreased in Cd4-cre+ Cin85F/F mice compared to control
Fig 6. Cin85-Deficiency results in defective clearance of LCMV-c13 and is correlated with decreased neutralizing antibody titer. (A, B) Analysis of
LCMV abundance in plasma in Cin85F/F and Cd4-cre+ Cin85F/F mice as determined by LCMV gp transcript levels (A) or focus forming assay (B) at day
80. Horizontal lines indicate median. The limit of detection is shown by dashed lines. Statistical significance was tested by Mann Whitney U-test. (C)
Frequencies of Fas+ GL7+ B220+ GC B cells at day 35 after LCMV-c13 infection. (D) anti-LCMV IgG antibody titers of plasma from Cin85F/F and Cd4-
cre+ Cin85F/F mice 30 days after LCMV-c13 infection. (E) Neutralizing activity of plasma from Cd2apF/F and Cd4-cre+ Cd2apF/F mice 80 days after
LCMV-c13 infection. Reduction in focus forming units (FFU) in the presence of 1:5 dilution of plasma compared to untreated control (%
Neutralization) is shown with mean and standard deviation. Student t-test. Data combined from 3 independent experiments are shown with n = 3–4
mice per genotype.
https://doi.org/10.1371/journal.ppat.1007053.g006
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Cin85F/F mice (Fig 6C) with anti-LCMV IgG titers unchanged, suggesting no severe defects in
the GC response (Fig 6D). However, plasma from infected Cd4-cre+ Cin85F/F mice exhibited a
significantly reduced neutralizing activity compared to plasma from cre− littermate controls
(Fig 6E). These results indicate that CIN85 is required for protective antibody responses in a T
cell-dependent manner presumably through controlling TFH function and potentially the qual-
ity of help provided to GC B cells with respect to generation of high-affinity neutralizing anti-
bodies required for clearance of chronic LCMV [27]. These results suggest that although
CD2AP and CIN85 share significant homology, their functions in antiviral CD4 T cell
responses are non-redundant, and potentially antagonistic.
Discussion
This study demonstrated that deletion of CD2AP in T cells results in skewing of CD4 T cell dif-
ferentiation towards TFH cells in response to viral infection, leading to enhanced control of
LCMV that requires GC-derived high affinity antibody responses [19, 21, 28]. TFH differentia-
tion was correlated with sustained TCR signaling under TH1 conditions, while TCR signaling
in vitro under non-TH1 conditions was not altered. Thus, our work revealed a specific role of
CD2AP in subset-specific CD4 T cell responses.
Sustained TCR stimulation during chronic LCMV infection or in the cancer microenviron-
ment causes deregulation of CD8 T cells, a phenomenon known as exhaustion [1], [29]. Fre-
quent interactions with cognate pMHC-I result in the persistent upregulation of several
inhibitory receptors which act to dampen T cell proliferation and effector functions, a hall-
mark of the “exhausted state” [2, 29]. However, the impact of sustained TCR stimulation on
the function of CD4 T cells has been less clearly understood. In chronic LCMV infection, CD4
T cells exhibit less IL-2 production and increased IL-10 production, a phenomenon that is sim-
ilar in nature to CD8 T cell “exhaustion” [3,30–32]. However, these CD4 T cells with the
altered activation state acquire the capability of producing IL-21, a key cytokine that enhances
the GC response and also supports the CD8 T cell response; both are required for control of
the viral infection [4, 31–33]. Thus, although sustained TCR signaling compromises CD8 T
cell functions, CD4 T cells are able to tolerate sustained signaling through TCR to mediate
pathogen control.
Several recent studies indicate that during chronic LCMV infection, CD4 T cells exhibit a
relatively unique propensity to acquire TFH features, a process that is dependent on continuous
antigen stimulation [5, 34]. The acquisition of TFH phenotype in chronic infection appears to
be different compared to acute LCMV infection [35]. Interestingly, in late phases >day 20 of
LCMV-c13 infection B cells do not appear to be absolutely required for the development of
CXCR5+ cells, suggesting other types of antigen presenting cells could contribute to the sus-
tained TFH response as this does not occur in MHCII KO [34]. Preferential TFH accumulation
has also been shown to be dependent on type-I Interferon [6, 36] which has not been explicitly
observed in acute contexts, via a cell-extrinsic mechanism, suggesting other soluble or cell-
associated factors could have a more direct influence [36]. These results illustrate the complex-
ity in direction of the CD4 T cell response, and illustrate the variety of mechanisms that influ-
ence the humoral response in response to the nature of the insulting pathogen. However, in
several contexts it appears that modulation of TCR affinity and or signal duration impacts the
differentiation of TFH cells, supporting a more broadly applicable role for the TCR.
Our study with CD2AP-deficient T cells confirm and extend previous studies that suggest
that sustained TCR signaling promotes TFH differentiation [37, 38]. Specifically, it was shown
following infection by Listeria monocytogenes that TCR:pMHCII dwell time correlated well
with GC-TFH differentiation [37]. In addition, in antigen-specific cells elicited by immunization
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with pigeon cytochrome c, TFH phenotype cells tended to have higher affinity for tetramer com-
pared to non-TFH cells, and transfer of TCR transgenic cells with higher affinity for pMHCII
revealed a preference for TFH differentiation [38]. One potential explanation is that TFH and
TH1 cells may share a transitional stage, at which sustained TCR signaling may restrict T-bet
upregulation to direct the activated CD4 T cells into the TFH subset, which favors low-T-bet
[39], while TFH differentiation during a type-2 immune response may require a distinct mecha-
nism. This may explain why TFH differentiation is enhanced when CD4 T cells receive sustained
TCR stimulation as antigen levels decline. Interestingly, enhanced TFH differentiation and
increased IL-21 expression by Cd2ap-deficient CD4 T cells did not noticeably alter the CD8 T
cell response, which is also dependent on CD4 T cell help. These results potentially indicate that
the nature of CD4 T cell help to B cells and CD8 T cells may be independent.
While downregulation of the TCR and subsequent termination of TCR downstream sig-
naling is broadly shared by T cells, our results indicate that CD2AP-dependent regulation of
TCR signaling duration is TH1-specific in vitro, which correlates with enhanced TFH differ-
entiation in LCMV infection. However, it still remains unclear whether the in vivo functions
of CD2AP are completely explained by TCR signaling via the immunological synapse, inter-
actions with CD2, or potentially via signaling via other cytokines such as IL-21 or Type I
interferon and is an area of further investigation. Notably, a recent study reported TH2-speci-
fic regulation of the duration of TCR signaling by the Rab-GTPase Dennd1b [40]. Dennd1b-
deficiency in CD4 T cells results in sustained TCR signaling and increased cytokine produc-
tion specifically under TH2 conditions. Furthermore, a DENND1B SNP in human, causing
reduced expression of its protein, is associated with asthma. These two studies, contrasting
lineage-specific requirement for CD2AP and Dennd1b in controlling TCR signaling in TH1
and TH2 cells, respectively, imply that the control of TCR signaling may be uniquely regu-
lated by different CD4 effector subsets. Despite strong correlations between sustained dura-
tion of TCR signaling in vitro and enhanced T cell polarization in vivo in Cd2ap-deficient
mice and Debbd1b-deficient mice, however, there may be additional mechanisms, such as
cell-cell contact or signaling through CD2, by which T cell polarization are enhanced in
these genetically modified mice.
Our study highlights CD2AP as a potential target for immunotherapy to enhance B cell
immune responses. Given the importance of high-affinity neutralizing antibodies in the clear-
ance of both acute and chronic viral infections or vaccines, boosting the GC response is an
attractive therapeutic target. The development of small molecules that inhibit the function of
CD2AP in the context of viral infection or in the context of vaccines, could enhance the anti-
body response. TFH responses, however, have also been associated with the development of
autoantibodies and autoimmunity.
Collectively, our results demonstrate that the quality of TCR signaling is regulated by dis-
tinct mechanisms in CD4 effector T cells, and regulates differentiation of antigen-specific CD4
T cells towards distinct subsets.
Materials and methods
Ethics statement
Overall care and use of the animals was consistent with The guide for the Care and Use of Labo-
ratory Animals from the National Research Council and the USDA Animal Care Resource
Guide and were performed according to a protocol approved by Washington University’s Ani-
mal Studies Committee under a protocol number of 20150187, which was approved on 10/26/
2015 and expires 10/9/2018. Euthanasia procedures are consistent with the “AVMA guidelines
for the Euthanasia of Animals 2013 edition.”
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Mice
C57BL/6N and B6-CD45.1 mice were purchased from Charles River Laboratory. Cd4-cre mice
in the C57BL/6 background were purchased from the Jackson Laboratory. A Cin85 (Sh3kbp1)-
floxed allele was described previously [26]. To generate a Cd2ap-flox allele, a genomic frag-
ment containing Cd2ap exon2 was flanked with two loxP sites and subcloned into a vector
containing a loxP-flanked neomycin resistant gene, a diphtheria toxin A (DTA) gene, and a
6.0-kb 5’ and a 2.1-kb 3’ homology arm. The targeting vector was electroporated into C57BL/
6-derived Bruce4 embryonic stem (ES) cells. After the selection with G418 (Thermofisher),
correctly targeted clones were identified by PCR. The neomycin resistant gene was removed
by a transient transfection of a cre expression vector. The targeted ES clones were injected into
blastocysts of BALB/c mice. The chimeric mice were crossed with C57BL/6 mice to obtain
germline transmission. To generate BM chimeras, B6-CD45.1 mice were lethally irradiated
(10.5 Gy) and reconstituted with donor BM cells for at least 8 weeks before experiments. All
mice were housed in a specific pathogen-free facility at Washington University in St. Louis,
and were analyzed at 8 to 10 weeks of age, unless stated otherwise. Both sexes were included
without randomization or blinding.
LCMV infection and immunization
Mice were infected with 2 x 105 plaque-forming units (PFU) of LCMV-Armstrong strain via
the intraperitoneal route or 2 x 106 (PFU) of LCMV-c13 by intravenous injection. For the
quantification of plasma viral load, RNA was extracted from 10 μL of plasma using Trizol (Life
Technologies). Before RNA extraction a spike-in of RNA extracted from 293T cells (American
Type Culture Collection, ATCC) expressing gfpmRNA was added to the plasma samples. The
amounts of the LCMV GP transcript relative to that of ‘‘spiked- in” gfpRNA were determined
by real-time qRT-PCR as previously described [21, 41]. For plasma viral titers, plasma was fro-
zen at -80˚C before performing plaque assay on Vero cells as previously described. Briefly, 7.5
x 105 Vero cells (ATCC) were plated per well of a 6-well plate 24 hour prior to incubation with
serial 10-fold dilutions of plasma in 200 μL of MEM/1%FBS (Thermofisher) for 1 hour at
37˚C. Following the incubation Vero cells were overlaid with 0.5% Agarose (Thermofisher)
solution in complete MEM and incubated for 5–6 days. Plaques were visualized following fixa-
tion in 1% PFA (Electron Microscopy Sciences) and staining with 0.1% crystal violet (Sigma).
In vitro neutralization assay was performed according to a published protocol with some
modifications [27]. Heat-inactivated (1 hr at 55˚C) plasma were serially diluted with media
and incubated with an equal volume of viral supernatant containing ~30–40 focus forming
units (FFU) of LCMV clone 13 at 37˚C for 90 min. 4 x 104 MC57G cells (ATCC) were added
to the virus mixture and once the cells had adhered to the plate ~4 hours, were overlaid with a
1% methylcellulose solution in completed DMEM. 40 hours following infection, overlay was
removed, and cells were fixed with 4% PFA for 1 hour at RT. Cells were permeabilized with
0.5% Triton X-100 in PBS and blocked with 10% FBS in PBS. Cells were stained with 1ug/mL
of anti-LCMV NP (VL-4; BioXCell) for 1 hour at RT followed by anti-rat IgG HRP. Foci were
developed using KPL TrueBlue Substrate.
Mice were immunized with 8–10 x 108 SRBC (Lampire) in 200 μL or with 100μg of
NP-CGG (Biosearch Technologies) precipitated Potassium Aluminum Sulfate (Sigma), via the
intraperitoneal route.
Flow cytometry and cell sorting
Single-cell suspensions were prepared by manual disruption of spleens with frosted glass
slides. Absolute cell counts were determined using Vi-Cell (Becton-Dickson). The following
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monoclonal antibodies were used: anti-CD4 (GK1.5; Biolegend), anti-CD8a (53–6.7; Biole-
gend), anti-CD25 (PC61; Biolegend), anti-CD44 (IM7; Biolegend), anti-CD45.2 (104; Biole-
gend), anti-CD45R (B220) (RA3-6B2; Biolegend), anti-CD62L (MEL-14; Biolegend), anti-
CD95 (Fas) (Jo2; BD Biosciences), anti-KLRG1 (2F1/KLRG1; Biolegend), anti-IFN-γ
(XMG1.2; eBioscience), anti-TCRb (H57-597; eBioscience), anti-PD-1 (29F.1A12; Biolgend),
anti-CXCR5 (2G8; BD Biosciences) or anti-CXCR5 (L138D7; Biolegend), anti-Ly6C (HK1.4;
Biolgend), and anti-GL7 antigen (GL7; Biolegend).
For sorting of naive CD8 T cells, splenocyte samples were initially depleted of B220+ cells
through the use of magnetic beads (Thermofisher). CD4 T cells were negatively selected using
the Dynabeads FlowComp Mouse CD4 Kit (Thermofisher) and then were stained with mono-
clonal antibodies to purify CD62L+ CD44− CD25− cells on a FACSAria II or FACSAriaIII
(BD Biosciences). For phenotypic analysis, cells were stained with monoclonal antibodies,
phycoerythrin (PE)-conjugated H-2Db-gp(33–41) (MBL International) for 1 hour at RT or
PE-I-Ab(gp66-77) (obtained from NIH Tetramer Core) for 90 minutes at 37˚C. Dead cells
were excluded by staining with DAPI (4,6-diamidino-2-phenylindole; Sigma). Data were ana-
lyzed with FlowJo software (TreeStar).
In Vitro T cell culture
Sort purified naive (CD62L+ CD44lo CD25−) CD4 or CD8 T cells were cultured in RPMI
1640 medium supplemented with 10% FBS (Thermofisher) and Gluta-MAX in the presence
of plate-bound anti-CD3 (145-2C11; Biolegend) and soluble anti-CD28 (37.51; Bio X Cell) at
concentrations of 0.1 μg/ml and 0.5 μg/ml, respectively, unless specified otherwise, in multi-
well tissue culture plates coated with rabbit antibody to hamster IgG (0855395; MP Biomedi-
cals). For TH1 polarization 10 ng/mL of IL-12 (R&D Systems) and 10 μg/mL of anti-IL-4
(11B11) were added to culture media. For TH2 polarization 10 ng/mL IL-4 (eBioscience),
10 μg/mL anti-IL-12 (BioXCell), and 10 μg/mL anti-IFN-γ (Biolegend) were added to culture
media. Following 3 days of anti-CD3 and anti-CD28 stimulation cells were removed from
stimulation and rested for 3 days in conditioned medium at concentration of 0.5–1 x 106
cells/mL. For CD8 T cell cultures, cells were cultured in 40 U/mL IL-2 during the resting
period.
Day 6 CD4 T cells were harvested, washed in fresh media, and restimulated using 50 ng/mL
PMA (Sigma) and 1 μM Ionomycin (Sigma) or plate-bound anti-CD3 (Biolegend) and soluble
anti-CD28 (BioXcell) as described above for the indicated times. For intracellular cytokine
analysis, Brefeldin A (Biolegend) was added to the cultures 2 hours before harvest. Supernatant
was collected 24 hours post-stimulation.
ELISA
ELISA for cytokines was performed on Nunc Maxisorp plates using ELISA MAX IFN-γ and
IL-4 kits (Biolegend) and developed using TMB substrate (Dako). OD450 values were read on a
spectrophotometer. Standard curves for these ELISAs were generated with purified cytokines.
Anti-LCMV ELISA was performed as previously described [42]. Nunc Polysorp plates
were coated with 10ug/mL sonicated cell lysate from LCMV-infected BHK-21 cells (gift from
Marco Colonna, Washington University) as capture antigen or uninfected BHK-21 cell lysate
overnight followed by UV irradiation (300 mJ in Stratalinker 1800; Stratagene). Plasma anti-
body was detected with biotinylated anti-mouse IgG1 antibody (BD) and anti-mouse IgG2c
antibody (1077–08; Southern Biotech). Endpoint titers were calculated by a sigmoidal-dose
response curve using a Graphpad Prism 7 software.
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Intracellular cytokine staining
Cells were subject to LIVE/DEAD Aqua staining (Thermofisher) for 30 minutes at 4˚C before
being fixed with 4% PFA for 10 minutes at RT. Cells were washed twice with 0.03% saponin
(Sigma) in 2% FBS/PBS before being stained with the indicated antibodies in 0.3% Saponin in
2% FBS/PBS for 20 min at 4˚C.
T cell stimulation and western blotting
In vitro polarized T cells were rested for 1 hour in cytokine-free RPMI medium before being
stained with 5 μg/mL anti-CD3 and 5 μg/mL anti-CD28 on ice for 20 minutes. TCR was then
crosslinked by addition of 20 μg/mL of anti-Armenian Hamster IgG to the cells on ice. Cells
were stimulated in 5 ml polystyrene tubes for the indicated times in a water bath at 37˚C. Cells
were lysed in NP-40 Lysis Buffer (1% NP-40, 50 mM Tris-HCl (pH7.5), 150 mM NaCl, 2 mM
EDTA, phosphatase inhibitors) and cleared via centrifugation at 14,000 rpm for 10 minutes,
then denatured in SDS sample buffer.
Lysates from equal numbers of cells were separated by 8% or 10% SDS PAGE and trans-
ferred to nitrocellulose membranes (Bio-Rad), which were incubated with primary antibodies
(identified below), followed by detection with horseradish peroxidase–conjugated species-spe-
cific antibody to immunoglobulin light chain (115-035-174 or 211-032-171; Jackson Immu-
noResearch) and a Luminata HRP substrate (Millipore). The following antibodies were used:
anti-CD2AP [10], anti-ERK2 (Santa Cruz, C-14), anti-p-MEK1/2 (Cell Signaling Technology,
9121).
RNA-sequencing
Total RNA was extracted from ~300,000 sorted cells using manufacturer’s instructions using
the RNA XS Kit (Macherey Nagel). cDNA synthesis and amplification were performed with a
Pico Input RNA Kit, according to the manufacturer’s instructions (Clontech). Libraries were
sequenced on a HiSeq3000 (Illumina) in single-read mode, with a read length of 50 nucleotides
producing ~25 million reads per sample. Sequence tags were mapped onto the NCBI37 mm9
with TopHat [43], followed by transcript assembly and Reads Per Kilo base of exon per Million
reads (RPKM) estimation using Cufflinks [44–46] on the Galaxy platform (https://usegalaxy.
org/). The raw data has been deposited at NCBI GEO with an accession number GSE112778.
Statistical analyses
Statistical analyses were performed with a two-tailed unpaired Student’s t-test or a Mann-
Whitney test using GraphPad Prism software.
Supporting information
S1 Fig. CD2AP is dispensable for T cell development. (A) Generation of a Cd2ap-flox allele
by gene targeting. Arrows indicate primer position for PCR. LA: long homology arm, SA:
short homology arm, Neo: neomycin resistance cassette, DTA: diphtheria toxin A. (B, C) Flow
cytometric analysis of expression of CD4, CD8, TCR, CD24 and CD69 in thymocytes (B) and
splenocytes (C) from Cd4-cre+ Cd2apF/F and control cre−Cd2apF/F mice. Numbers indicates
percentages of cells surrounded by rectangle or polygon gates. Data are representative of 3–6
mice in 2 independent experiments.
(TIF)
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S2 Fig. Time-course of GC B cell response following SRBC and NP-CGG immunization in
Cd2ap deficient mice. (A, C, E) Flow cytometric analysis of expression of PD-1 and CXCR5
on pre-gated CD4+ B220− T cells and GL7 and Fas expression on CD19+ B220+ B Cells at 6
days (A), 22 days (C) following SRBC immunization, and 10 days following Alum precipitated
NP-CGG immunization (E). (B, D, F) Numbers and frequencies of CXCR5+ PD-1+ TFH and
Fas+ GL7+ GC B cells in the spleen of Cd4-cre+ Cd2apF/F and control Cd2apF/F mice at 6 days
(B), 22 days (D) after immunization with SRBC, and 10 days following Alum precipitated
NP-CGG immunization (F). Data are representative of 2 independent experiments shown as
means and standard deviation.
(TIF)
S3 Fig. Analysis of GC response in CD2AP deficient mice following LCMV-c13 infection.
(A) Analysis of viral plaque forming units (PFU) in Cd2apF/F and Cd4-cre+ Cd2apF/F mice at
day 45 of LCMV-c13 infection. (B) Expression of PD-1 and CXCR5 in CD4 T cells at day 22 of
LCMV-c13 infection in Cd2apF/F and Cd4-cre+ Cd2apF/F mice (C-D) Absolute numbers of (C)
CD4 T cells, and TFH cells (CXCR5
+PD-1+) and (D) B cells at day 22 of LCMV-c13 infection
in Cd2apF/F and Cd4-cre+ Cd2apF/F mice. (E, F) Frequencies of Foxp3+ TFH cells 22 days fol-
lowing LCMV-c13 infection of Cd2apF/F and Cd4-cre+ Cd2apF/F mice. (G) Anti-LCMV IgG1
antibody titers of plasma from Cd2apF/F and Cd4-cre+ Cd2apF/F mice 60 days after LCMV-c13
infection. (H) Frequencies of Ki67+ TFH cells 22 days following LCMV-c13 infection of
Cd2apF/F and Cd4-cre+ Cd2apF/F mice. (I) Expression of ICOS and OX-40 in Naive CD4 (PD-
1− CD44lo) CD4 T cells and CXCR5+ PD-1+ TFH cells 22 days following LCMV-Armstrong
infection in Cd2apF/F and Cd4-cre+ Cd2apF/F mice. Data are representative of 2 independent
experiments with n = 3–6 mice per genotype.
(TIF)
S4 Fig. Analysis of GC output following LCMV-c13 infection. (A-B) Expression of B220,
IgM, IgD, GL7, AA4.1, CD138, and CD24 of splenocytes (A) and bone marrow cells (B) of
Cd2apF/F and Cd4-cre+ Cd2apF/F 60 days after LCMV-c13 infection. (C-D) Absolute numbers
of memory B cells in the spleen (C) and plasma cells in the bone marrow (D) in Cd2apF/F and
Cd4-cre+ Cd2apF/F mice 60 days after LCMV-c13 infection. Data are representative of 2 inde-
pendent experiments shown as means and standard deviation.
(TIF)
S5 Fig. CD8 T cell response in CD2AP deficient mice is comparable to control mice follow-
ing LCMV-c13 infection. (A) Expression of CD8, CD4, CD44 and PD-1 and binding of H-
2Db(gp33-41) in Cd2apF/F and Cd4-cre+ Cd2apF/F mice 22 days after LCMV-c13 infection (B)
Absolute quantification of (A) (C) Splenocytes from Cd2apF/F and Cd4-cre+ Cd2apF/F mice 22
days after LCMV-c13 infection were stimulated with gp33-41 peptide and the expression of
IFN-γ and TNF-α was analyzed. Data are representative of 2 independent experiments with
n = 4–6 mice per genotype.
(TIF)
S6 Fig. Intact CD8 and CD4 T cell response to LCMV Armstrong in T cell-specific Cin85
deficient mice. (A) Expression of IFN-γ, TNF-α, and IL-21 in splenocytes from day 8
LCMV-Armstrong following stimulation with gp61-80 peptide in Cin85F/F and CD4-cre+
Cin85F/F animals (B) Expression of CD4, CD8, and CD44, and binding of H-2Db(gp33-41)
and H-2Db(np396-404) tetramers of splenocytes from Cin85F/F and Cd4-cre+ Cin85F/F mice
eight days after LCMV-Armstrong infection. (C) Expression of CD19, B220, GL7, and Fas
eight days after LCMV-Armstrong infection in Cin85F/F and Cd4-cre+ Cin85F/F mice (D, E)
Absolute quantification of cell numbers from Cin85F/F and Cd4-cre+ Cin85F/F mice. Data are
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representative of 2 independent experiments of n = 4–6 mice each shown as means and stan-
dard deviation.
(TIF)
S7 Fig. Delayed clearance of LCMV-c13 in Vav1-icre Cin85F/F mice. (A) Plasma viral abun-
dance of LCMV determined by gp transcripts in Cin85F/F and Vav1-icre+ Cin85F/F. (B-D) Fre-
quencies and absolute numbers of (B) H-2Db(gp33-41)-specific CD8+ cells (C) I-Ab(gp66-77)-
specific CD4 T cells and CXCR5+ PD-1+ CD4 T cells, and (D) Fas+ GL7+ B cells in the spleen
day 30 post-infection in LCMV-c13 infection in Cin85F/F and Vav1-icre+ Cin85F/F mice. Data
combined from three independent experiments of n = 2–3 mice each.
(TIF)
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